相关实验视频

Updated: Jan 18, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

解决和调节:纳米平台协调STING的可用性和激动剂的输送,以加强抗瘤免疫疗法

Yu Sun¹, Hideki Nakanishi², Xiaonan Huang³

¹Laboratory of Cell Glycobiology, School of Biotechnology and Key Laboratory of Carbohydrate Chemistry and Biotechnology of Ministry of Education, Jiangnan University, Wuxi, 214122, PR China; Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China.

|September 9, 2025

概括

这项研究介绍了DecG@Al,这是一种新的平台,可以增强用于癌症免疫治疗的STING通路激活. 它克服了分娩和沉默障碍,导致强大的瘤抑制和改善生存率.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
纳米技术纳米技术

背景情况:

干扰素基因刺激 (STING) 途径是癌症免疫疗法的关键目标.
基于循环二核酸 (CDN) 的STING激动剂的临床使用受到细胞质输送不良和瘤特异性STING沉默的限制.
瘤STING沉默通过DNA甲基转移酶介导的促进剂高甲基化发生.

研究的目的:

设计一个双作用平台,DecG@Al,以克服阻碍癌症中STING通路激活的障碍.
将氧化 (Alum),2'3'-cGAMP和decitabine结合起来,以增强CDN传输和STING恢复.
评估DecG@Al在重编程瘤微环境和抑制瘤生长方面的有效性.

主要方法:

开发了DecG@Al,这是一个集Alum,2'3'-cGAMP和decitabine的平台.
评估了DecG@Al提高2'3'-cGAMP和decitabine生物可用性的通过膜传递的能力.
利用B16F10黑色素瘤模型来评估免疫调节效应和瘤抑制.

主要成果:

DecG@Al协同增强了细胞内CDN-STING复合体和STING通路的激活.
DecG@Al重新编程了免疫抑制瘤微环境,促进M1巨细胞和激活树突细胞.
DecG@Al治疗导致了强烈的瘤抑制,延长了生存时间,并减少了CD8+ T细胞耗尽,毒性最小.

结论:

DecG@Al有效地解决了CDN-STING复合体形成不足的根本原因.
这种在临床上可转换的策略有望重新激发抗瘤免疫力.
DecG@Al提供了一种新的方法来增强基于STING的癌症免疫疗法.

关键词:

2′3′-cGAMPP 的使用情况.在这里,我们可以看到Alum Alum.抗瘤免疫疗法免疫疗法德西塔胺 (Decitabine) 是一种药物刺痛是一种刺痛.

更多相关视频

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.